|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/107 | |
| A61K 9/28 | |||
| A61K 9/51 | |||
| A61K 38/06 | |||
| A61K 45/06 |
| (11) | Patento numeris | 2001400 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07753175.4 |
| Europos patento paraiškos padavimo data | 2007-03-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2008-12-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-05-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2007/006528 |
| Data | 2007-03-14 |
| (87) | Numeris | WO 2007/106555 |
| Data | 2007-09-20 |
| (30) | Numeris | Data | Šalis |
| 782148 P | 2006-03-14 | US |
| (72) |
WEN, Jingyuan, NZ
THOMAS, Gregory Brian, AU
BICKERDIKE, Mike John, NZ
|
| (73) |
Neuren Pharmaceuticals Limited,
Level 1, 59 Wellington Street Freemans Bay, Auckland 1011,
NZ
Wen, Jingyuan, 94 Harold Street, Mt. Eden, NZ Thomas, Gregory Brian, 10 Grangemouth Turn, Kinross,, Perth WA 6028, AU Bickerdike, Mike John, 41 Waimarie Street, St. Heliers, Auckland, NZ |
| (54) | ORAL FORMULATIONS OF GLYCYL-2-METHYLPROLYL-GLUTAMATE |
| ORAL FORMULATIONS OF GLYCYL-2-METHYLPROLYL-GLUTAMATE |